ZELDA Therapeutics Limited (ASX: ZLD) has increased its international footprint by trading on the US public market as it looks to attract North American investors into the medicinal cannabis company. Its shares have been approved for trading on the OTCQB Venture Market (OTCQB) in the United States … Read More
The post Cannabis company begins trading in the US appeared first on Dagga Magazine.